[Form 4] Design Therapeutics, Inc. Insider Trading Activity
Justin D. Gover, a director of Design Therapeutics, Inc. (DSGN), reported two option grants dated 09/09/2025. The filing shows awards of 30,000 and 15,833 stock options with an exercise price of $6.64 each, representing 45,833 underlying shares in total. The reporting form lists these as direct holdings. The filing includes vesting schedules: the 30,000-option award vests in equal monthly installments over 36 months following September 9, 2025, and the 15,833-option award vests in equal monthly installments over 12 months following September 9, 2025. The form was signed on behalf of the reporting person on 09/10/2025.
Justin D. Gover, amministratore di Design Therapeutics, Inc. (DSGN), ha segnalato due assegnazioni di opzioni datate 09/09/2025. La comunicazione indica premi di 30.000 e 15.833 opzioni azionarie con un prezzo di esercizio di $6,64 ciascuna, per un totale di 45.833 azioni sottostanti. Il modulo di segnalazione riporta questi titoli come detenuti direttamente. Il documento include i piani di maturazione: l'assegnazione di 30.000 opzioni matura in rate mensili uguali per 36 mesi a partire dal 9 settembre 2025, mentre l'assegnazione di 15.833 opzioni matura in rate mensili uguali per 12 mesi a partire dal 9 settembre 2025. Il modulo 猫 stato firmato per conto della persona che segnala il 10/09/2025.
Justin D. Gover, director de Design Therapeutics, Inc. (DSGN), inform贸 sobre dos concesiones de opciones fechadas el 09/09/2025. El documento muestra adjudicaciones de 30.000 y 15.833 opciones sobre acciones con un precio de ejercicio de $6.64 cada una, lo que representa 45.833 acciones subyacentes en total. El formulario de notificaci贸n indica que estas participaciones son tenencias directas. La presentaci贸n incluye los calendarios de consolidaci贸n: la adjudicaci贸n de 30.000 opciones se consolida en cuotas mensuales iguales durante 36 meses a partir del 9 de septiembre de 2025, y la adjudicaci贸n de 15.833 opciones se consolida en cuotas mensuales iguales durante 12 meses a partir del 9 de septiembre de 2025. El formulario fue firmado en nombre de la persona informante el 10/09/2025.
Design Therapeutics, Inc. (DSGN)鞚� 鞚挫偓 Justin D. Gover臧� 2025雲� 9鞗� 9鞚检瀽 霊� 瓯挫潣 鞀ろ啞鞓奠厴 攵�鞐ゼ 氤搓碃頄堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頄夓偓臧� $6.64鞚� 30,000欤� 氚� 15,833欤� 鞓奠厴鞚� 臧侁皝 攵�鞐悩鞏� 齑� 45,833欤检潣 旮办磮 欤检嫕鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃 鞏戩嫕鞐愲姅 頃措嫻 氤挫湢臧� 歆侅爲 氤挫湢(direct holdings)搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滌棎電� 氩犾姢韺� 鞚检爼鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟: 30,000鞓奠厴 攵�鞐秳鞚� 2025雲� 9鞗� 9鞚� 鞚错泟 36臧滌洈 霃欖晥 毵れ洈 霃欖澕頃� 牍勳湪搿� 氩犾姢韸鸽悩氅�, 15,833鞓奠厴 攵�鞐秳鞚� 2025雲� 9鞗� 9鞚� 鞚错泟 12臧滌洈 霃欖晥 毵れ洈 霃欖澕頃� 牍勳湪搿� 氩犾姢韸鸽惄雼堧嫟. 頃措嫻 鞏戩嫕鞚� 2025雲� 9鞗� 10鞚检棎 氤搓碃鞚胳潉 雽�鞁犿晿鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Justin D. Gover, administrateur de Design Therapeutics, Inc. (DSGN), a d茅clar茅 deux attributions d'options dat茅es du 09/09/2025. Le d茅p么t indique des attributions de 30 000 et 15 833 options d'achat d'actions au prix d'exercice de 6,64 $ chacune, soit un total de 45 833 actions sous-jacentes. Le formulaire de d茅claration mentionne ces titres comme des d茅tentions directes. Le dossier inclut les calendriers d'acquisition : l'attribution de 30 000 options acquiert des droits par mensualit茅s 茅gales sur 36 mois 脿 compter du 9 septembre 2025, et l'attribution de 15 833 options acquiert des droits par mensualit茅s 茅gales sur 12 mois 脿 compter du 9 septembre 2025. Le formulaire a 茅t茅 sign茅 au nom de la personne d茅clarante le 10/09/2025.
Justin D. Gover, Direktor von Design Therapeutics, Inc. (DSGN), meldete zwei Optionszuteilungen vom 09.09.2025. Die Einreichung weist Auszeichnungen 眉ber 30.000 und 15.833 Aktienoptionen mit einem Aus眉bungspreis von jeweils $6,64 aus, was insgesamt 45.833 zugrundeliegende Aktien entspricht. Das Meldeformular f眉hrt diese als Direktbeteiligungen auf. Die Einreichung enth盲lt Vesting-Pl盲ne: die Zuteilung von 30.000 Optionen vestet in gleichen monatlichen Raten 眉ber 36 Monate ab dem 9. September 2025, die Zuteilung von 15.833 Optionen vestet in gleichen monatlichen Raten 眉ber 12 Monate ab dem 9. September 2025. Das Formular wurde am 10.09.2025 im Namen der meldenden Person unterschrieben.
- Equity-based compensation disclosed showing alignment of the director's incentives with shareholder value through time-based vesting
- Clear vesting schedules (36 months and 12 months) that promote multi-year retention
- None.
Insights
TL;DR: Director received equity compensation totaling 45,833 options at $6.64, with multi-year vesting schedules.
The Form 4 documents routine equity awards to a company director rather than open-market trading or dispositions. The aggregate grant of 45,833 options creates potential future dilution only if exercised; the filing specifies direct ownership and structured vesting (36 months and 12 months), which aligns the director's incentives with multi-year retention. There are no cash proceeds or dispositions reported and no other compensatory details disclosed in this filing.
TL;DR: Grants reflect standard retention-based compensation with defined monthly vesting schedules.
The disclosed awards appear to be time-based stock options issued to a director, with explicit monthly vesting over one and three years respectively. Such vesting schedules are common governance tools to promote continuity of service. The Form 4 does not disclose grant rationale, proportionality to total outstanding equity, or acceleration terms, limiting assessment of material governance implications.
Justin D. Gover, amministratore di Design Therapeutics, Inc. (DSGN), ha segnalato due assegnazioni di opzioni datate 09/09/2025. La comunicazione indica premi di 30.000 e 15.833 opzioni azionarie con un prezzo di esercizio di $6,64 ciascuna, per un totale di 45.833 azioni sottostanti. Il modulo di segnalazione riporta questi titoli come detenuti direttamente. Il documento include i piani di maturazione: l'assegnazione di 30.000 opzioni matura in rate mensili uguali per 36 mesi a partire dal 9 settembre 2025, mentre l'assegnazione di 15.833 opzioni matura in rate mensili uguali per 12 mesi a partire dal 9 settembre 2025. Il modulo 猫 stato firmato per conto della persona che segnala il 10/09/2025.
Justin D. Gover, director de Design Therapeutics, Inc. (DSGN), inform贸 sobre dos concesiones de opciones fechadas el 09/09/2025. El documento muestra adjudicaciones de 30.000 y 15.833 opciones sobre acciones con un precio de ejercicio de $6.64 cada una, lo que representa 45.833 acciones subyacentes en total. El formulario de notificaci贸n indica que estas participaciones son tenencias directas. La presentaci贸n incluye los calendarios de consolidaci贸n: la adjudicaci贸n de 30.000 opciones se consolida en cuotas mensuales iguales durante 36 meses a partir del 9 de septiembre de 2025, y la adjudicaci贸n de 15.833 opciones se consolida en cuotas mensuales iguales durante 12 meses a partir del 9 de septiembre de 2025. El formulario fue firmado en nombre de la persona informante el 10/09/2025.
Design Therapeutics, Inc. (DSGN)鞚� 鞚挫偓 Justin D. Gover臧� 2025雲� 9鞗� 9鞚检瀽 霊� 瓯挫潣 鞀ろ啞鞓奠厴 攵�鞐ゼ 氤搓碃頄堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頄夓偓臧� $6.64鞚� 30,000欤� 氚� 15,833欤� 鞓奠厴鞚� 臧侁皝 攵�鞐悩鞏� 齑� 45,833欤检潣 旮办磮 欤检嫕鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃 鞏戩嫕鞐愲姅 頃措嫻 氤挫湢臧� 歆侅爲 氤挫湢(direct holdings)搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滌棎電� 氩犾姢韺� 鞚检爼鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟: 30,000鞓奠厴 攵�鞐秳鞚� 2025雲� 9鞗� 9鞚� 鞚错泟 36臧滌洈 霃欖晥 毵れ洈 霃欖澕頃� 牍勳湪搿� 氩犾姢韸鸽悩氅�, 15,833鞓奠厴 攵�鞐秳鞚� 2025雲� 9鞗� 9鞚� 鞚错泟 12臧滌洈 霃欖晥 毵れ洈 霃欖澕頃� 牍勳湪搿� 氩犾姢韸鸽惄雼堧嫟. 頃措嫻 鞏戩嫕鞚� 2025雲� 9鞗� 10鞚检棎 氤搓碃鞚胳潉 雽�鞁犿晿鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Justin D. Gover, administrateur de Design Therapeutics, Inc. (DSGN), a d茅clar茅 deux attributions d'options dat茅es du 09/09/2025. Le d茅p么t indique des attributions de 30 000 et 15 833 options d'achat d'actions au prix d'exercice de 6,64 $ chacune, soit un total de 45 833 actions sous-jacentes. Le formulaire de d茅claration mentionne ces titres comme des d茅tentions directes. Le dossier inclut les calendriers d'acquisition : l'attribution de 30 000 options acquiert des droits par mensualit茅s 茅gales sur 36 mois 脿 compter du 9 septembre 2025, et l'attribution de 15 833 options acquiert des droits par mensualit茅s 茅gales sur 12 mois 脿 compter du 9 septembre 2025. Le formulaire a 茅t茅 sign茅 au nom de la personne d茅clarante le 10/09/2025.
Justin D. Gover, Direktor von Design Therapeutics, Inc. (DSGN), meldete zwei Optionszuteilungen vom 09.09.2025. Die Einreichung weist Auszeichnungen 眉ber 30.000 und 15.833 Aktienoptionen mit einem Aus眉bungspreis von jeweils $6,64 aus, was insgesamt 45.833 zugrundeliegende Aktien entspricht. Das Meldeformular f眉hrt diese als Direktbeteiligungen auf. Die Einreichung enth盲lt Vesting-Pl盲ne: die Zuteilung von 30.000 Optionen vestet in gleichen monatlichen Raten 眉ber 36 Monate ab dem 9. September 2025, die Zuteilung von 15.833 Optionen vestet in gleichen monatlichen Raten 眉ber 12 Monate ab dem 9. September 2025. Das Formular wurde am 10.09.2025 im Namen der meldenden Person unterschrieben.
FAQ
What insider transaction did Justin D. Gover (DSGN) report on Form 4?
What is the exercise price of the options reported by the director (DSGN)?
How do the reported options vest according to the Form 4?
Are the reported option holdings direct or indirect?
When was the Form 4 signed and filed?
